Human umbilical cord mesenchymal stem cell‑derived exosomes improve ovarian function in natural aging by inhibiting apoptosis
International Journal of Molecular Medicine · 23.08.2023 · 52 (4)
DOI: 10.3892/ijmm.2023.5297 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Medicine, online erschienen am 23.08.2023. Verfasst von Zhongkang Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China. Hauptthemen laut MEDLINE: Exosomes, MicroRNAs, Mesenchymal Stem Cells. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Prolonging the reproductive lifespan is beneficial for preserving the physical and psychological health of women. The transplantation of mesenchymal stem cell (MSC)‑derived exosomes (MSC‑Exos) has been reported to be a promising regenerative therapeutic strategy for restoring the function of aging ovaries. The present study thus evaluated the therapeutic efficacy of exosomes derived from human umbilical cord‑MSCs (hUCMSC‑Exos) in a mouse model of natural ovarian aging (NOA), and further investigated the role of exosomal microRNAs (miRNAs/miRs) in the mechanisms of this creative therapy. Specifically, following the administration of hUCMSC‑Exos in mice with NOA, ovarian function was found to improve, as indicated by the restoration of follicle numbers and hormone levels. These exosomes were found to exhibit the ability to inhibit PTEN expression and suppress apoptosis both in vivo and in vitro. Subsequently, miRNA sequencing of the exosomes was performed, following which bioinformatics analysis was used to identify the highly expressed miRNAs that are capable of targeting PTEN expression. Through high‑throughput sequencing and molecular analyses, miR‑21‑5p was found to be the highest in ranking in terms of expression, suggesting that hUCMSC‑Exos can preserve ovarian function by suppressing PTEN expression to inhibit apoptosis by delivering miR‑21‑5p. On the whole, the results of the present study suggest that the application of exosomes can be used to restore ovarian function in mice with NOA. These positive findings also suggest that the transplantation of exosomes derived from MSCs holds promise as an agent against ovarian aging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China.
- R&D Department, Shandong Qilu Cell Therapy Engineering Technology Co., Ltd., Jinan, Shandong 25000, P.R. China.
- Department of Surgery, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China.
Zitieren
APA
Li, Z., Liu, Y., Tian, Y., Li, Q., Shi, W., Zhang, J., Zhang, H., Tan, Y., Yang, S., Yang, T., Huang, X., & Du, Y. (2023). Human umbilical cord mesenchymal stem cell‑derived exosomes improve ovarian function in natural aging by inhibiting apoptosis. International Journal of Molecular Medicine, 52(4). https://doi.org/10.3892/ijmm.2023.5297
Vancouver
Li Z, Liu Y, Tian Y, Li Q, Shi W, Zhang J, et al. Human umbilical cord mesenchymal stem cell‑derived exosomes improve ovarian function in natural aging by inhibiting apoptosis. International Journal of Molecular Medicine. 2023;52(4). doi:10.3892/ijmm.2023.5297
BibTeX
@article{Li2023,
author = {Li, Zhongkang and Liu, Yibin and Tian, Yanpeng and Li, Qian and Shi, Wenxin and Zhang, Jingkun and Zhang, Huihui and Tan, Yi and Yang, Shuangshuang and Yang, Tao and Huang, Xianghua and Du, Yanfang},
title = {Human umbilical cord mesenchymal stem cell‑derived exosomes improve ovarian function in natural aging by inhibiting apoptosis},
journal = {International Journal of Molecular Medicine},
year = {2023},
volume = {52},
number = {4},
doi = {10.3892/ijmm.2023.5297}
}
EUVIMED